Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paton

Showing results (231-240 of 4,763) with videos related to

Pageof 477
Sort By:
Postgraduate Medical Journal|October 1, 1987
Upstream medicineA Paton
Journal of Medical Ethics|June 1, 1983
Vivisection, morals, medicine: commentary from a vivisecting professor of pharmacologyW Paton
Postgraduate Medical Journal|August 1, 1988
Helping handsA Paton
Nature Reviews. Microbiology|February 8, 2006
Designer probiotics for prevention of enteric infectionsAdrienne W Paton, Renato Morona, James C Paton
Nature Medicine|March 4, 2000
A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humansA W Paton, R Morona, J C Paton
Infection and Immunity|May 16, 2002
Characterization of a novel type IV pilus locus encoded on the large plasmid of locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humansPotjanee Srimanote, Adrienne W Paton, James C Paton
Discovery Medicine|January 20, 2007
Treatment and prevention of enteric infections with toxin-binding probioticsAdrienne W Paton, Renato Morona, James C Paton
The Journal of Infectious Diseases|September 1, 2007
Pathologic changes in mice induced by subtilase cytotoxin, a potent new Escherichia coli AB5 toxin that targets the endoplasmic reticulumHui Wang, James C Paton, Adrienne W Paton
Expert Review of Gastroenterology & Hepatology|June 10, 2010
Receptor-mimic probiotics: potential therapeutics for bacterial toxin-mediated enteric diseasesAdrienne W Paton, Renato Morona, James C Paton
Bioengineered Bugs|February 18, 2011
Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infectionsAdrienne W Paton, Renato Morona, James C Paton
Pageof 477

Showing results (231-240 of 4,763) with videos related to

Sort By:
Pageof 477
Postgraduate Medical Journal|October 1, 1987
Upstream medicineA Paton
Journal of Medical Ethics|June 1, 1983
Vivisection, morals, medicine: commentary from a vivisecting professor of pharmacologyW Paton
Postgraduate Medical Journal|August 1, 1988
Helping handsA Paton
Nature Reviews. Microbiology|February 8, 2006
Designer probiotics for prevention of enteric infectionsAdrienne W Paton, Renato Morona, James C Paton
Nature Medicine|March 4, 2000
A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humansA W Paton, R Morona, J C Paton
Infection and Immunity|May 16, 2002
Characterization of a novel type IV pilus locus encoded on the large plasmid of locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humansPotjanee Srimanote, Adrienne W Paton, James C Paton
Discovery Medicine|January 20, 2007
Treatment and prevention of enteric infections with toxin-binding probioticsAdrienne W Paton, Renato Morona, James C Paton
The Journal of Infectious Diseases|September 1, 2007
Pathologic changes in mice induced by subtilase cytotoxin, a potent new Escherichia coli AB5 toxin that targets the endoplasmic reticulumHui Wang, James C Paton, Adrienne W Paton
Expert Review of Gastroenterology & Hepatology|June 10, 2010
Receptor-mimic probiotics: potential therapeutics for bacterial toxin-mediated enteric diseasesAdrienne W Paton, Renato Morona, James C Paton
Bioengineered Bugs|February 18, 2011
Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infectionsAdrienne W Paton, Renato Morona, James C Paton
Pageof 477